New Oral Anticoagulants: General Features and Review of Pivotal Clinical Trials

New Oral Anticoagulants: General Features and Review of Pivotal Clinical Trials

For the last half century, vitamin K antagonists (VKAs) have been used for treatment and prevention of venous thromboembolism and stroke prevention in patients with atrial fibrillation. However, their fragile pharmacokinetics, need for routine laboratory monitoring and dose adjustments complicated t...

Full description

Bibliographic Details
Main Author:	Sung-Won Jang
Format:	Article
Language:	English
Published:	Yong Chan Lee 2016-12-01
Series:	The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:	Thrombin Factor Xa Anticoagulants Atrial fibrillation Venous thromboembolism
Online Access:	http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2016.16.4.178

Similar Items

Use of anticoagulants in elderly patients: practical recommendations
by: Helia Robert-Ebadi, et al.
Published: (2009-04-01)

NEW ORAL ANTICOAGULANT DRUGS IN ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROME
by: Aleksandra Novaković, et al.
Published: (2013-09-01)

Emergence of new oral antithrombotics: a critical appraisal of their clinical potential
by: Michael Rud Lassen, et al.
Published: (2008-12-01)

A call to action for anticoagulation stewardship
by: Allison E. Burnett, et al.
Published: (2022-07-01)

Changes in anticoagulant prescription in a general hospital in 2008-2018
by: E. B. Kleymenova, et al.
Published: (2021-09-01)

Prediction Score for Anticoagulation Control Quality Among Older Adults
by: Kueiyu Joshua Lin, et al.
Published: (2017-10-01)

Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription
by: Maral Koolian, et al.
Published: (2022-08-01)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
by: Neil A. Zakai, et al.
Published: (2021-08-01)

Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism
by: Dongwon Yoon, et al.
Published: (2023-09-01)

The Discovery of Dabigatran Etexilate
by: Joanne evan Ryn, et al.
Published: (2013-02-01)

Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy
by: João Presume, et al.
Published: (2024-02-01)

Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?
by: Anna Maria Gori, et al.
Published: (2022-12-01)

Characterization of Thrombin Generation Curve Shape in Presence of Platelets from Acute Venous Thromboembolism Patients
by: Jeremy Lagrange, et al.
Published: (2020-09-01)

The novel anticoagulants: entering a new era
by: Swiss Medical Weekly
Published: (2009-02-01)

Dabigatran etexilate - A novel oral anticoagulant for bleeding complications
by: Himabindu Reddy, et al.
Published: (2015-09-01)

Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic Disorders
by: Elena Campello, et al.
Published: (2022-10-01)

Evaluating efficacy and safety of oral anticoagulation in adult patients with atrial fibrillation and cancer: A systemic review and meta-analysis
by: L.A. Ciuffini, et al.
Published: (2023-08-01)

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines
by: Afsaneh Vazin, et al.
Published: (2022-12-01)

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
by: Anne Gulbech Ording, et al.
Published: (2021-07-01)

Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea
by: Seongwook Han, et al.
Published: (2021-10-01)

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials
by: Florian Moik, et al.
Published: (2020-05-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences
by: Claire Khouja, et al.
Published: (2022-10-01)

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
by: Ashley Chen, et al.
Published: (2020-07-01)

Assessment and predictors of inappropriate dose of direct oral anticoagulants
by: Mosaad O. Almegren
Published: (2024-01-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
by: Keun-Sik Hong
Published: (2019-09-01)

On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects
by: David Hutto, et al.
Published: (2022-06-01)

Edoxaban in venous thromboembolism and stroke prevention: an appraisal
by: Proietti M, et al.
Published: (2016-02-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
by: Nikolay Runev, et al.
Published: (2019-06-01)

EXPERIENCE IN THE USE OF ORAL ANTICOAGULANTS IN OUTPATIENT CLINICS
by: T. V. Voskresenskaya, et al.
Published: (2017-11-01)

UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey
by: Kathrine Parker, et al.
Published: (2023-01-01)

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study
by: Maxim Grymonprez, et al.
Published: (2023-08-01)

Use of direct oral anticoagulants in ICU patients. Part II – Clinical evidence
by: Abdul Wahab, et al.
Published: (2021-11-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

Anticoagulation therapy in older patients at risk for syncopal and not-syncopal fall and/or frailty. An AcEMC-GIMSI multidisciplinary consensus document
by: Ivo Casagranda, et al.
Published: (2020-03-01)

The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New?
by: N. M. Vorobyeva, et al.
Published: (2020-12-01)

Mortality associated with the use of non‐vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban
by: Yu‐Sheng Lin, et al.
Published: (2021-10-01)

Electrochemical Monitoring in Anticoagulation Therapy
by: Ashwin K. V. Mruthunjaya, et al.
Published: (2024-03-01)

How to level the risk of bleeding while taking anticoagulant therapy in patients with atrial fibrillation?
by: Svetlana A. Berns, et al.
Published: (2022-01-01)